Concepedia

Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia

Carly Oboudiyat, Tamar Gefen, Eleni A. Varelas, Sandra Weıntraub, Emily Rogalskı, Eileen H. Bigio, M.‐Marsel Mesulam

Alzheimer s & Dementia · 2017 · 22 citations · 12 references

DOIFull text

Open access

Abstract

CSF biomarkers reliably identified Alzheimer pathology in nonamnestic dementias and may be useful as a screening measure for inclusion of nonamnestic cases into Alzheimer's trials.

References

12

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Katya Rascovsky, John R. Hodges, David S. Knopman et al. · Brain · 2011 · 5.1K citations · Full text

, , +15

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

Thomas J. Montine, Creighton H. Phelps, Thomas G. Beach et al. · Acta Neuropathologica · 2011 · 2.8K citations · Full text

, , +11

The Determinants of Quality of Life of Nursing Home Residents with Young-Onset Dementia and the Differences between Dementia Subtypes

Britt Appelhof, Christian Bakker, Jeannette C.L. van Duinen‐van den IJssel et al. · Dementia and Geriatric Cognitive Disorders · 2017 · 2.8K citations · Full text

Primary progressive aphasia

M.‐Marsel Mesulam · Annals of Neurology · 2001 · 974 citations

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

Tero Tapiola, Irina Alafuzoff, Sanna‐Kaisa Herukka et al. · Archives of Neurology · 2009 · 880 citations · Full text